As part of the larger trend of pharmacy groups and retail chains looking to broaden the scope of pharmacy work, the ASHP said pharmacists should be reimbursed for administering COVID-19 vaccines and treatments, according to a news release.
Reimbursement seems to be a key issue for pharmacists: After months of lobbying, HHS authorized pharmacists to administer the monkeypox vaccine Sept. 30, but reimbursement wasn’t mentioned, which some have said is an unsustainable model.
During the conversation, CMS officials also raised concerns about unclear guidelines for clinicians prescribing Paxlovid — Pfizer’s COVID-19 antiviral treatment that the FDA decided in July to allow pharmacists to prescribe. In response to the clearance, the American Medical Association president said the prescribing requirements for Paxlovid are “far beyond a pharmacist’s scope and training.”
After the November meeting, the ASHP said it would work to quell confusion among providers about Paxlovid use and when it can be dispensed in hospitals.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.